The startup develops dietary supplements that enhance gut health by converting dietary sugars into plant fiber through specific microbial fermentation processes. This approach aims to improve gastrointestinal function and mitigate diet-related diseases.
Funding
$3.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional approaches to improving nutrition in processed foods often rely on reformulated recipes and ingredient substitutions, which can compromise taste and consumer satisfaction. This can lead to "better-for-you" products that fail to engage a wider audience and make it difficult for people to stick to new dietary habits.
Solution
Zya leverages the power of naturally-derived enzymes to transform how our bodies process food, enhancing nutritional outcomes without sacrificing taste. Their technology, centered around the enzyme Convero, converts up to 30% of sugar into dietary fiber in the gut during digestion. This approach allows food brands to maintain the taste and texture consumers love while adding nutritional benefits, such as reduced sugar absorption and increased prebiotic fiber intake. Zya's enzyme solutions seamlessly integrate into existing food products, offering a subtle yet powerful change in how society approaches health.
Target Audience
Zya's primary customers are CPG companies and food manufacturers looking to innovate and lead in nutritional advancements by enhancing the nutritional profiles of their existing products without compromising taste.
Features
- Convero enzyme technology that converts up to 30% of sugar into dietary fiber in the gut.
- Retains the original taste and texture of food products without reformulation.
- Increases prebiotic fiber intake, promoting a healthy gut microbiome.
- Reduces sugar absorption, contributing to better metabolic health.
- Seamless integration into existing food manufacturing processes.
- Supported by research collaborations with organizations like Boston Bioprocess, Aminoverse, and Aelius Biotech.